News Heading : Piramal Pharma stock in focus after EIR from USFDA for Ahmedabad facility
Description : Piramal Pharma Share Price | In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) designation.
Link for further : https://www.moneycontrol.com/news/business/stocks/piramal-pharma-shares-in-focus-post-eir-from-usfda-for-ahmedabad-facility-12831688.html
